The new frontiers of medicine have significantly increased cancer survival.
Healed patients wish to return to normal even if partially “invalidated” by the consequences of the therapies.
One of the most painful consequences is infertility.
Today, in Western countries, only a small percentage of cancer patients benefit from advice on the possibility of preserving fertility before starting treatments and without affecting its effectiveness. Doctors play a key role in spreading this message.
Some preservation techniques are no longer considered experimental and therefore from an ethical point of view it is unfair, and from a legal point of view it is dangerous not to give the patient detailed and complete information in this field.
Access to the preservation of fertility is part of the broader field of support, including psychological support, which is of great interest in the patient’s recovery process.
A psychological support that helps to plan life in a perspective of normality after treatment appears to be of fundamental importance, as much as the treatment itself. It has been shown that the preservation of fertility also represents an important motivation for adhering more strongly to the therapeutic path. The aim of this survey is to understand the knowledge of the oncological gynecologists of the MITO group on the new frontiers in the field of fertility preservation in patients affected by oncological pathologies.